Total Debt (Carrying Amount)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Debt item | Description | The company |
---|---|---|
Total loans payable and long-term debt, including current portion (carrying amount) | Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. | Merck & Co. Inc. total debt decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level. |
Total Debt (Fair Value)
Dec 31, 2023 | |
---|---|
Selected Financial Data (US$ in millions) | |
Total loans payable and long-term debt, including current portion (fair value) | 32,000) |
Financial Ratio | |
Debt, fair value to carrying amount ratio | 0.91 |
Based on: 10-K (reporting date: 2023-12-31).
Weighted-average Interest Rate on Debt
Weighted-average interest rate on loans payable and long-term debt: 3.32%
Interest rate | Debt amount1 | Interest rate × Debt amount | Weighted-average interest rate2 |
---|---|---|---|
2.75% | 2,498) | 69) | |
2.15% | 1,988) | 43) | |
2.75% | 1,980) | 54) | |
3.70% | 1,979) | 73) | |
3.40% | 1,740) | 59) | |
4.50% | 1,547) | 70) | |
1.70% | 1,495) | 25) | |
2.90% | 1,484) | 43) | |
5.00% | 1,481) | 74) | |
4.00% | 1,473) | 59) | |
4.15% | 1,240) | 51) | |
1.45% | 1,238) | 18) | |
2.45% | 1,214) | 30) | |
1.88% | 1,103) | 21) | |
0.75% | 996) | 7) | |
1.90% | 995) | 19) | |
5.15% | 987) | 51) | |
3.90% | 986) | 38) | |
2.35% | 985) | 23) | |
4.30% | 745) | 32) | |
4.90% | 740) | 36) | |
6.50% | 707) | 46) | |
1.38% | 548) | 8) | |
2.50% | 548) | 14) | |
4.05% | 497) | 20) | |
3.60% | 492) | 18) | |
6.55% | 406) | 27) | |
5.75% | 339) | 19) | |
5.95% | 307) | 18) | |
5.85% | 271) | 16) | |
6.40% | 250) | 16) | |
6.30% | 135) | 9) | |
4.82% | 289) | 14) | |
Total | 33,683) | 1,120) | |
3.32% |
Based on: 10-K (reporting date: 2023-12-31).
1 US$ in millions
2 Weighted-average interest rate = 100 × 1,120 ÷ 33,683 = 3.32%